@RetinaToday

Supporting Patients Throughout Their GA Journey

Editorially Independent Content, Supported With Advertising From Asetllas

View Insert

3 Years After Pegcetacoplan Approval: Addressing Post-Injection Complications and Understanding EZ:RPE Loss as a Potential Measure of Clinical Response

Content Sponsored by Apellis, A subsidiary of Biogen

View Supplement

Business Matters: Leveraging Data in the Retina Practice

Editorially independent content supported with advertising by Eyepoint

View Supplement

One to Watch: Alexis Warren, MD

Editorially independent supported by Abbvie and Regenxbio

View Insert

Defining Early Geographic Atrophy Requires More Than Lesion Size

Editorially Independent Content, Supported With Advertising From Astellas

View Insert

Rising Stars: Jonathan Lin, MD, PhD

Editorially independent supported by Abbvie and Regenxbio

View Insert